BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11042520)

  • 1. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
    Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
    J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.
    Wilson WH; Kingma DW; Raffeld M; Wittes RE; Jaffe ES
    Blood; 1996 Jun; 87(11):4531-7. PubMed ID: 8639820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder.
    Yamamoto T; Shirakawa A; Kawaguchi M; Masuda A; Nishikawa T; Kobayashi M
    Ann Hematol; 2004 Feb; 83(2):127-32. PubMed ID: 14530876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
    Yu M; Zhang Q; Xu S; Yin T; Li F
    Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma.
    Ohno T; Miyake N; Hada S; Hirose Y; Imura A; Hori T; Uchiyama T; Saiga T; Mizumoto T; Furukawa H
    Cancer; 1998 May; 82(10):1963-72. PubMed ID: 9587131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
    Hayashi K; Joko H; Koirala TR; Onoda S; Jin ZS; Munemasa M; Ohara N; Oda W; Tanaka T; Oka T; Kondo E; Yoshino T; Takahashi K; Yamada M; Akagi T
    Histol Histopathol; 2003 Oct; 18(4):1155-68. PubMed ID: 12973684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
    Su IJ; Wang CH; Cheng AL; Chen RL
    Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
    Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; MoliniƩ V; Dubertret L
    Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
    Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
    Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma arising in patient with a history of EBV-positive mucocutaneous ulcer and EBV-positive nodal polymorphous B-lymphoproliferative disorder.
    Daroontum T; Kohno K; Inaguma Y; Okamoto A; Okamoto M; Kimura Y; Nagahama M; Sakakibara A; Satou A; Nakamura S
    Pathol Int; 2019 Jan; 69(1):37-41. PubMed ID: 30450620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
    Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
    Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.
    Hayashi K; Jin Z; Onoda S; Joko H; Teramoto N; Ohara N; Oda W; Tanaka T; Liu YX; Koirala TR; Oka T; Kondo E; Yoshino T; Takahashi K; Akagi T
    Am J Pathol; 2003 May; 162(5):1721-36. PubMed ID: 12707056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.